CDEK
← All drugs Report issue

tqb2618

mAbexperimental

Clinical trial activity

10 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
9
Phase 2
5
Phase 3
0
Phase 4
0

Earliest trial started Dec 1, 2020 (NCT04623892)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2022

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06010901Phase 1Sep 30, 2023Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT05975645Phase 1Aug 31, 2023Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT05834543Phase 1/Phase 2 (Phase 2)May 31, 2023Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT05783921Phase 1/Phase 2 (Phase 2)May 23, 2023Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT05563480Phase 2Oct 27, 2022Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT05451407Phase 1Aug 31, 2022Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT05400876Phase 1/Phase 2 (Phase 2)Jun 30, 2022Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT05426798Phase 1Apr 29, 2022Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT05645315Phase 1/Phase 2 (Phase 2)Apr 28, 2022Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT04623892Phase 1Dec 1, 2020Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,LtdFor profit101022020
1 organizations
Page 1 / 1